Shasqi
PrivateLast Round
Grant
Dec 8, 2021
Est. Valuation
$1.79M
Total Funding Raised
$64.03M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Shasqi is a biotechnology company that develops cancer therapeutics using its proprietary CAPAC (Click Activated Protodrugs Against Cancer) platform, which utilizes in vivo click chemistry for targeted drug delivery to tumor sites to enhance efficacy and minimize systemic toxicity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shasqi Comparables
Compare Shasqi with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tagworks Pharmaceuticals | 88% | |
| Avacta Group | 75% | |
| CytomX Therapeutics | 74% | |
Shasqi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 8, 2021 | ||||
| Series B | Nov 11, 2021 | ||||
| Grant | Apr 27, 2021 | ||||
| Series A | Oct 31, 2019 | ||||
| Seed | Jul 20, 2016 | ||||
Accelerator | Jan 1, 2015 |
Shasqi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Y Combinator | Seed, Accelerator, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 58% MoM.
- Nov 11, 2021
Raised $50M with participation from Bill Rieflin and Juan Jaen.
Shasqi Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shasqi's valuation, stock price, and market status.